STK17B and hepatocellular carcinoma: Furthermore, the results of Transwell migration and invasion assays confirmed that STK17B silencing inhibited and STK17B overexpression promoted HCC cell motility and invasiveness (Fig. 3b; Supplementary Figure 3a and b).